BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

AvenCell Secures Up to $40 Million AMED Grant to Advance Dual-Antigen Allogeneic CAR-T Therapy

AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapie...

July 02, 2025 | News

HanchorBio Licenses Novel CD47 Fusion Protein HCB101 to Henlius in $200 Million+ Regional Deal

HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, annou...

July 02, 2025 | News

Klotho Neurosciences Advances KLTO-202 Gene Therapy Manufacturing for ALS Clinical Trials

Klotho Neurosciences, Inc. announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of K...

July 01, 2025 | News

Porton Advanced and EVA Pharma Partner to Boost CAR T-Cell Therapy Manufacturing in the Middle East and Africa

Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies d...

June 27, 2025 | News

Invetech and AiCella Forge Strategic Alliance to Advance AI-Driven Cell Therapy Manufacturing

Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today anno...

June 27, 2025 | News

AGC Biologics Launches Cell Therapy Manufacturing Services in Yokohama to Expand Global CDMO Footprint

AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc....

June 26, 2025 | News

Xcell Biosciences and Thermo Fisher Scientific Unite to Advance Treg and TIL Cell Therapies for Autoimmune and Solid Tumor Diseases

Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic coll...

June 25, 2025 | News

Terumo BCT Showcases 3-in-1 CAR-T Manufacturing Protocol in Cytotherapy

Protocol published in Cytotherapy1 shows activation and viral transduction can be performed on Terumo BCT’s Quantum Cell Expansion System.&nbs...

June 19, 2025 | News

HELP Therapeutics and China Resources Sanjiu Forge Strategic Partnership to Advance Groundbreaking iPSC-Derived Therapy for Heart Failure in China

HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest pharmaceut...

June 17, 2025 | News

Nuevocor Receives FDA IND Clearance to Advance NVC-001 Gene Therapy for LMNA-Related Dilated Cardiomyopathy

LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United...

June 11, 2025 | News

Neowise Licenses TCR Technology to BeOne Medicines for Off-the-Shelf iPSC-Based Cell Therapy Development

Neowise Biotechnology ("Neowise"), a pioneering company focused on the development of TCR-T cell therapies for solid tumors, announced today that it has en...

June 10, 2025 | News

YolTech Therapeutics Receives FDA IND Clearance for In Vivo Base Editing Therapy YOLT-101

YolTech Therapeutics, a clinical-stage biotechnology company developing in vivo genome editing therapies, announced that the U.S. Food and Drug ...

June 09, 2025 | News

Elpis Biopharmaceuticals and Singapore General Hospital Partner to Advance Next-Gen CAR-γδT Cell Therapies for AML and Multiple Myeloma

Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, today announced entry into ...

June 05, 2025 | News

JW Therapeutics Secures Macao Approval for CAR-T Therapy Carteyva®, Marking First Overseas Market Entry

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunother...

June 05, 2025 | News

Stay Connected